Sonic Healthcare Limited SKHCF OTC · Healthcare · Australia
$13.60 -0.15% -$0.02
Summary
56 / 100 · Bulios Score
What speaks for it
- The share price is below the Bulios Fair Price.
- Revenue grew by 10% a year over the last 3 years.
What to watch
- Earnings per share fell by 5.3% a year over the last 3 years.
- It pays out more in dividends than it earns: 109% of profit.
- It missed profit estimates 4 times in the last 8 quarters.
- It earns only 5.6 AUD a year on every 100 AUD of invested capital.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapBy our assumptions the business is worth more than its shares cost today.
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 16.3 AUD for 1 AUD of yearly profit.
Valuation in detailIs it growing?
It is shrinkingRevenue (AUD)
Diluted EPS (AUD)
- Analyst estimate
Revenue grew by 4.5% a year over 5 years. Over the last 3 years it grew by 10% a year. For the next fiscal year analysts expect revenue to fall by 0.4%. Earnings per share fell by 5.3% a year over the last 3 years.
Growth in detailDoes it make money?
ReasonablyWhere 100 AUD of revenue goes
- Cost of sales 72 AUD
- Sales and administration 18 AUD
- Taxes and other 4.4 AUD
- Net profit 5.6 AUD
Net profit, industry median (Medical - Diagnostics & Research) 9.9 AUD
Out of every 100 AUD of revenue, 5.6 AUD is left as net profit.
Profitability in detailIs it financially healthy?
Debt is a burdenRepaying all its debt would take 7.5 years of free cash flow. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
High, at risk- Yield
- 6.66%
- Paid out of profit
- 109%
You receive $0.91 per share a year. The payout is more than the company can comfortably cover.
Dividends in detailWhat do analysts expect?
No coverageNo analyst covers this stock.
Analysts in detailWhat does it earn on?
By product
The company reports no revenue by product.
By region
The company reports no revenue by region.